BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 119455
Published online Sep 19, 2026. doi: 10.5498/wjp.119455
Table 3 Baseline data comparison (development vs external validation), n (%)

Development cohort (n = 145)
External validation cohort (n = 53)
t/χ2
P value
Nonunion17 (11.72)10 (18.87)1.6820.195
Age (years)47.69 ± 14.8649.28 ± 14.060.6770.499
Gender0.0130.909
Male100 (68.97)37 (69.81)
Female45 (31.03)16 (30.19)
Body mass index (kg/m2)23.87 ± 3.0024.97 ± 3.132.2480.026
Bone defect length (mm)40.01 ± 13.0041.92 ± 13.110.9170.360
Distraction start time (days)10.48 ± 3.889.51 ± 3.211.6320.104
Distraction period (days)43.07 ± 9.8243.62 ± 8.860.3600.719
Bone mineralization time (days)201.26 ± 92.78208.42 ± 94.270.4790.633
Open fracture38 (26.21)15 (28.30)0.0870.768
Comorbidity
Hypertension63 (43.45)23 (43.40)0.0070.995
Diabetes28 (19.31)12 (22.64)0.2670.605
Atherosclerosis25 (17.24)10 (18.87)0.0710.791
Depression (PHQ-9)11.93 ± 3.7014.96 ± 3.305.2490.000
Anxiety (GAD-7)11.06 ± 3.9513.13 ± 2.814.3130.000
Social support (MSPSS)57.62 ± 10.9560.28 ± 11.211.5050.134
Current smoker44 (30.34)16 (30.19)0.0800.983
Low-income earner59 (40.69)23 (43.40)0.1170.732


Write to the Help Desk